{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:42:45Z","timestamp":1769604165093,"version":"3.49.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81671235"],"award-info":[{"award-number":["No. 81671235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1093\/jnen\/nly017","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T10:31:48Z","timestamp":1520418708000},"page":"395-404","source":"Crossref","is-referenced-by-count":9,"title":["Revisiting Pathological Classification Criteria for Adult Idiopathic Inflammatory Myopathies: In-Depth Analysis of Muscle Biopsies and Correlation Between Pathological Diagnosis and Clinical Manifestations"],"prefix":"10.1093","volume":"77","author":[{"given":"Ying","family":"Hou","sequence":"first","affiliation":[{"name":"Research Institute of Neuromuscular and Neurodegenerative Diseases and Department of Neurology, Qilu Hospital, Shandong University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Bei","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingjun","family":"Dai","sequence":"additional","affiliation":[{"name":"Research Institute of Neuromuscular and Neurodegenerative Diseases and Department of Neurology, Qilu Hospital, Shandong University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Shao","sequence":"additional","affiliation":[{"name":"Center of Laboratory Medicine, Qilu Hospital (Qingdao), Qingdao, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Research Institute of Neuromuscular and Neurodegenerative Diseases and Department of Neurology, Qilu Hospital, Shandong University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Research Institute of Neuromuscular and Neurodegenerative Diseases and Department of Neurology, Qilu Hospital, Shandong University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Qiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine\/Neuropathology, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[{"name":"Research Institute of Neuromuscular and Neurodegenerative Diseases and Department of Neurology, Qilu Hospital, Shandong University, Jinan, Shandong, China"},{"name":"Mitochondrial Medicine Laboratory, Qilu Hospital (Qingdao), Qingdao, Shandong, China"},{"name":"Brain Science Research Institute, Shandong University, Jinan, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"key\n\t\t\t\t20180413102400_nly017-B1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180413102400_nly017-B2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nmd.2013.07.007","article-title":"193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands","volume":"23","author":"De Bleecker","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180413102400_nly017-B3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC International Workshop: pathology diagnosis of idiopathic inflammatory myopathies part II 28\u201330 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180413102400_nly017-B4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180413102400_nly017-B5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180413102400_nly017-B6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180413102400_nly017-B7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A randomized, pilot trial of etanercept in dermatomyositis","volume":"70","author":"Muscle Study G","year":"2011","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","article-title":"A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients","volume":"73","author":"Higgs","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180413102400_nly017-B9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.apmr.2016.09.125","article-title":"Postrehabilitation functional improvements in patients with inflammatory myopathies: the results of a randomized controlled trial","volume":"98","author":"Tiffreau","year":"2017","journal-title":"Arch Phys Med Rehabil"},{"key":"key\n\t\t\t\t20180413102400_nly017-B10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180413102400_nly017-B11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180413102400_nly017-B12","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/acr.22068","article-title":"Improvement in health and possible reduction in disease activity using endurance exercise in patients with established polymyositis and dermatomyositis: a multicenter randomized controlled trial with a 1-year open extension followup","volume":"65","author":"Alemo Munters","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key\n\t\t\t\t20180413102400_nly017-B13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3109\/s10165-011-0534-4","article-title":"Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial","volume":"22","author":"Miyasaka","year":"2012","journal-title":"Mod Rheumatol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/mus.24681","article-title":"Efficacy and safety of creatine supplementation in juvenile dermatomyositis: a randomized, double-blind, placebo-controlled crossover trial","volume":"53","author":"Solis","year":"2016","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20180413102400_nly017-B15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3899\/jrheum.120804","article-title":"Classification and diagnostic investigation in inflammatory myopathies: a study of 99 patients","volume":"40","author":"Danielsson","year":"2013","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B16","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/rheumatology\/kev229","article-title":"Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience","volume":"54","author":"Klein","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20180413102400_nly017-B17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jneuroim.2014.07.006","article-title":"Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies","volume":"274","author":"Suzuki","year":"2014","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","article-title":"Long-term follow-up of 62 patients with myositis","volume":"261","author":"van de Vlekkert","year":"2014","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.nmd.2014.01.002","article-title":"Myopathy with anti-signal recognition particle antibodies: clinical and histopathological features in Chinese patients","volume":"24","author":"Wang","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20180413102400_nly017-B20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key\n\t\t\t\t20180413102400_nly017-B21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1212\/01.wnl.0000299087.17204.6d","article-title":"Polymyositis: not a unicorn or mythological beast\u2026but maybe a duck?","volume":"70","author":"Kissel","year":"2008","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180413102400_nly017-B22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"key\n\t\t\t\t20180413102400_nly017-B23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archneurol.2011.1728","article-title":"Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome","volume":"69","author":"Suzuki","year":"2012","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B24","doi-asserted-by":"crossref","first-page":"i82","DOI":"10.1136\/annrheumdis-2011-200587","article-title":"New approaches to the assessment and treatment of the idiopathic inflammatory myopathies","volume":"71(Suppl 2)","author":"Miller","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180413102400_nly017-B25","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian","year":"2015","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B26","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180413102400_nly017-B27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.24307","article-title":"Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy","volume":"51","author":"Van De Vlekkert","year":"2015","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20180413102400_nly017-B28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/WNL.0000000000002863","article-title":"Anti-TIF1-gamma antibody and cancer-associated myositis: a clinicohistopathologic study","volume":"87","author":"Hida","year":"2016","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20180413102400_nly017-B29","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/MD.0000000000000416","article-title":"Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan","volume":"94","author":"Watanabe","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180413102400_nly017-B30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/rheumatology\/keu422","article-title":"Magnetic resonance imaging changes of thigh muscles in myopathy with antibodies to signal recognition particle","volume":"54","author":"Zheng","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"key\n\t\t\t\t20180413102400_nly017-B31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t20180413102400_nly017-B32","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","article-title":"Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile","volume":"181","author":"Preusse","year":"2012","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B33","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"key":"key\n\t\t\t\t20180413102400_nly017-B34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.410190203","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. III: immunoelectron microscopy aspects of cell-mediated muscle fiber injury","volume":"19","author":"Arahata","year":"1986","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ana.410160207","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. II: phenotypes of autoinvasive cells in polymyositis and inclusion body myositis","volume":"16","author":"Engel","year":"1984","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B36","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180413102400_nly017-B37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20180413102400_nly017-B38","author":"Allenbach"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnen\/article-pdf\/77\/5\/395\/24615341\/nly017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T10:24:19Z","timestamp":1523615059000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/77\/5\/395\/4924616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,3,7]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nly017","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,3,7]]}}}